Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

7.1%

1 terminated out of 14 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

29%

4 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

88% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (6)
P 1 (1)
P 2 (3)
P 3 (3)
P 4 (1)

Trial Status

Completed7
Recruiting3
Unknown2
Not Yet Recruiting1
Terminated1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07414693Phase 4Recruiting

Effect of Vitamin C on Length of Hospital Stay in Children With Severe Pneumonia

NCT07302828Not ApplicableCompletedPrimary

Effect of Double Nutri® Liposomal Encapsulation Technology on Human Absorption of Vitamin C and Glutathione Liquid Sachet

NCT05770596Not ApplicableCompletedPrimary

Vitamin C on Acute and Chronic Post Mastectomy Pain

NCT07076108Not ApplicableCompletedPrimary

Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis

NCT07121036Phase 1RecruitingPrimary

High - Dose Vitamin C Infusion Regimen Based on Pharmacokinetic Characteristics for Patients With Advanced Malignant Solid Tumors

NCT06995586Not ApplicableNot Yet Recruiting

Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.

NCT04046861Not ApplicableCompleted

Influence of High Vitamin C Dose on Lactate During and After Extracorporeal Circulation

NCT06780345Not ApplicableCompletedPrimary

Role of Vitamin C Infusion in Postoperative Mechanically Ventilated Neonates With Sepsis

NCT04516681Phase 3Recruiting

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

NCT04401150Phase 3CompletedPrimary

Lessening Organ Dysfunction With VITamin C - COVID-19

NCT05694975Phase 2UnknownPrimary

Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients.

NCT03680274Phase 3Completed

Lessening Organ Dysfunction With VITamin C

NCT04264533Phase 2TerminatedPrimary

Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia

NCT02083575Phase 2UnknownPrimary

Role of Vitamin C to Augment Iron Chelation With DFP or DFX

Showing all 14 trials

Research Network

Activity Timeline